As IL-6 inhibition comes into practice for PMR, research advances on other therapeutic mechanisms of action, from IL-17 to ...
Learn about polymyalgia rheumatica (PMR) symptoms and treatment. Understand the sudden start of pain and how it is different from arthritis.
Novartis said that its immunology drug Cosentyx met the primary target and all secondary ones in a late-stage trial for the treatment of patients with inflammatory disease polymyalgia rheumatica.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results